Delphinus Medical Technologies

Novi, MI · Founded 2010 · Privately Held (backing)

Developer of an ultrasound system designed to transform the early detection of breast cancer. Delphinus Medical Technologies is based in Novi, MI and was founded in 2010. It was valued at $210 million at its later-stage round in Aug 2023, the last priced event on record. It has raised $161 million across 5 recorded rounds; the latest was a $27.6 million debt round in Mar 2024.

PMV mark · valuation
$210.0M
Oct 2026
Priced at
its later-stage round
Aug 2023
Total raised
$161.4M
Last round
Debt
Mar 2024
No prints on record

No secondary trades in Delphinus Medical Technologies shares have been recorded yet. When market activity lands it appears here as monthly aggregates and, for platform-recorded trades, dated prints.

Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Delphinus Medical Technologies with a free account
  • ·The complete investor list: 14 names
  • ·Watch Delphinus Medical Technologies: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Where Delphinus Medical Technologies prices come from

Secondary marks are indicative month-end price levels observed across secondary-market trading venues — a level, not a trade — and are the market input to the PrivateMarketView mark. Private share prices aren’t published anywhere. Aggregate figures combine multiple reporting channels — direct participant reports, platform transactions, third-party market intelligence — at monthly granularity. Individually dated prints are a Pro feature and are shown only for transactions recorded on our own platform. Third-party-reported trades are never republished individually, at any tier. Verified prints (✓) have been confirmed against a second source. Prints marked SPV or Forward reflect the structure’s pricing, which can differ from direct share transfers of Delphinus Medical Technologies stock.